Prepair 500+
Gene: GLA
Fabry disease: childhood onset clinical symptoms, life-threatening complications involving kidneys, heart and cerebrovascular systems
Fabry disease, cardiac variant: later-onset typically only affecting heart, kidneys, or blood vessels in brain
Female carriers can experience significant medical complications
Treatments: carbamazepine for neuropathic pain, enzyme replacement therapy available to prevent or delay disease progressionCreated: 3 Sep 2024, 1:07 a.m. | Last Modified: 3 Sep 2024, 1:07 a.m.
Panel Version: 1.248
Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Phenotypes
Fabry disease, 301500, (3)
Publications
Well established gene disease association. Associated with 2 forms:
Classic FD: onset of clinical symptoms occurs in pediatric patients. Life‐threatening complications involving the kidneys, heart and cerebrovascular system may develop
Cardiac variant/Atypical FD: sually presents in the sixth to eighth decade
Enzyme replacement therapy (ERT) is available to prevent and/or delay disease progression
Female carriers experience significant clinical manifestationsCreated: 21 Jul 2022, 6:25 a.m. | Last Modified: 21 Jul 2022, 6:25 a.m.
Panel Version: 0.61
Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Phenotypes
Fabry disease (MIM#301500)
Publications
Gene: gla has been classified as Green List (High Evidence).
Publications for gene: GLA were set to 29649853; 20301469
gene: GLA was added gene: GLA was added to Prepair 500+. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: GLA was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: GLA were set to 29649853; 20301469 Phenotypes for gene: GLA were set to Fabry disease, MIM#301500